Mind Medicine (MindMed) Inc MNMD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
2.45UNCH (UNCH)
Volume
243,863
Close
2.45quote price arrow up+0.01 (+0.41%)
Volume
4,982,244
52 week range
0.33 - 5.77
Loading...
  • Open2.48
  • Day High2.48
  • Day Low2.41
  • Prev Close2.44
  • 52 Week High5.77
  • 52 Week High Date04/27/21
  • 52 Week Low0.33
  • 52 Week Low Date09/17/20

Key Stats

  • Market Cap900.29M
  • Shares Out368.54M
  • 10 Day Average Volume3.46M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-19.67

KEY STATS

  • Open2.48
  • Day High2.48
  • Day Low2.41
  • Prev Close2.44
  • 52 Week High5.77
  • 52 Week High Date04/27/21
  • 52 Week Low0.33
  • 52 Week Low Date09/17/20
  • Market Cap900.29M
  • Shares Out368.54M
  • 10 Day Average Volume3.46M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-19.67

RATIOS/PROFITABILITY

  • EPS (TTM)-0.18
  • P/E (TTM)-13.59
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date11/11/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mind Medicine (MindMed) Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Mind Medicine (MindMed) Inc., formerly Broadway Gold Mining Ltd., is a neuro-pharmaceutical company. The Company discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The Company addresses the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.
Perry Dellelce
Chairman
Jamon Rahn
Chief Executive Officer
Miriam Wernli
President
Carol Nast
Chief Operating Officer
David Guebert CPA
Chief Financial Officer
Bradford Cross
Chief Technology Officer
Address
1166 Alberni Steet, Suite 1604
Vancouver, BC
V6E 3Z3
Canada